CapsoVision, Inc. (CV)
NASDAQ: CV · Real-Time Price · USD
4.290
+0.070 (1.66%)
Aug 7, 2025, 4:00 PM - Market closed
Blueprint Medicines Employees
CapsoVision had 90 employees as of December 31, 2024.
Employees
90
Change
n/a
Growth
n/a
Revenue / Employee
$133,822
Profits / Employee
-$234,144
Market Cap
199.37M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 90 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CV News
- 7 days ago - CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025 - GlobeNewsWire
- 5 weeks ago - CapsoVision Announces Closing of Initial Public Offering - GlobeNewsWire
- 5 weeks ago - CapsoVision Announces Pricing of Initial Public Offering - GlobeNewsWire
- 5 weeks ago - U.S. IPO Weekly Recap: Consumer Collections Firm Leads 4 IPO Week, As Two Billion Dollar Listings Join The Pipeline - Seeking Alpha
- 2 months ago - CapsoVision Proposes IPO Terms For GI Tract Imaging Capsule Technology - Seeking Alpha
- 3 months ago - Medical device maker CapsoVision files for a $30 million IPO - Renaissance Capital
- 3 months ago - CapsoVision IPO Registration Document (S-1) - SEC